Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome

Table 3 Biochemical profile in chronic HCV patients at start, 3 and 6 mo of breathwalking (BW) (mean ± SD)

Biochemical parameter	Basal	3 mo	6 mo
Glucose (mg/dL)	94.0 ± 16.5	93.5 ± 21.8	87.2 ± 12.3
	(77-128)	(71-142)	(75-121)
ALT (U/L)	106.6 ± 93.1	82.8 ± 63.4	59.4 ± 32.7b
	(18-349)	(20-241)	(17-112)
AST (U/L)	101.4 ± 66.6	87.8 ± 61.8	84.7 ± 61.8
	(32-265)	(20-226)	(24-241)
ALT/AST ratio	1.04	0.94	0.70b
Total bilirubin (mg/dL)	1.38 ± 1.2	1.22 ± 1.1	0.62 ± 0.36b
	(0.30-5.2)	(0.29-4.9)	(0.0-1.1)
Cholesterol (mg/dL)	157.1 ± 86.5	148.0 ± 38.4	146.0 ± 39.8
	(103-231)	(82-217)	(67-205)
Triglycerides (mg/dL)	165.0 ± 86.5	141.9 ± 46.4	124.6 ± 49.2b
	(86-378)	(85-210)	(64-197)
TG/HDL ratio	4.0	3.9	2.7a

Data are expressed in mean ± SD. TG/HDL: Triglycerides/high density lipoprotein.

^aP < 0.05,

^bP < 0.01 between baseline and 3 or 6 mo.